CNS Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

CNS Pharmaceuticals

11/11/2024 15:31

* CNS Pharmaceuticals Inc  CNSP.OQ   CNSP.O  is expected
to report
resultson November 13 (estimated) for the period ending January
1 0001
    * 
    * ​LSEG's mean analyst estimate for CNS Pharmaceuticals Inc
is for
a loss of 10 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for CNS
Pharmaceuticals Inc is $0.50​, above​ its last closing price
of $0.12. ​​​

This summary was machine generated November 11 at 15:31 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)